Phytochemical Profiling and Pharmacoinformatics Reveal Proliverenol from Phaleria macrocarpa as a Multi-Target Hepatoprotective Modulator of MAFLD
Pharmaceuticals · 17.03.2026 · 19 (3) · 491
DOI: 10.3390/ph19030491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 17.03.2026. Verfasst von Fahrul Nurkolis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Master of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya 60131, Indonesia. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Albanian University Research Fund., Albanian University Research Fund.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a highly prevalent chronic liver disorder driven by complex metabolic, inflammatory, and oxidative mechanisms with no effective pharmacological therapy currently available. Although the multi-target natural product Proliverenol, derived from Phaleria macrocarpa pericarp, has shown hepatoprotective potential in preclinical and early clinical studies, its molecular mechanisms in MAFLD remain unclear.
Objective
This study aimed to elucidate the multi-target hepatoprotective mechanisms of Proliverenol in MAFLD by integrating untargeted phytochemical profiling, network pharmacology, and molecular docking approaches.
Methods
Untargeted LC–HRMS/MS analysis was performed to characterize the phytochemical composition of Proliverenol (Veprolin™). Identified compounds were subjected to target fishing, followed by protein–protein interaction (PPI) network construction, cluster analysis, and functional enrichment (GO and KEGG). Key MAFLD-related targets were further validated using molecular docking against major signaling proteins implicated in inflammation, apoptosis, and metabolic regulation.
Results
Fourteen bioactive compounds were annotated, dominated by flavonoids and organic acids, including several phenolic acid derivatives, with phalerin as the most abundant constituent. Network pharmacology identified overlapping targets between Proliverenol, MAFLD, and hepatotoxicity, forming a highly interconnected PPI network. Functional enrichment revealed significant involvement in apoptosis regulation, inflammatory signaling, oxidative stress response, lipid metabolism, and insulin resistance pathways. Molecular docking demonstrated strong binding affinities of several Proliverenol constituents—particularly cucumerin B, artoindonesianin P, and vitexin 2″-p-hydroxybenzoate—toward key targets including PTGS2, SIRT1, GSK3B, RELA, and MCL1, with affinities comparable to or exceeding those of reference drugs.
Conclusions
Proliverenol exerts hepatoprotective effects through coordinated multi-target modulation of inflammatory, metabolic, and apoptotic pathways relevant to MAFLD. While these findings provide mechanistic insights based on integrative metabolomics and computational analyses, the absence of direct experimental validation represents an important limitation. Therefore, further in vitro, in vivo, and clinical investigations are warranted to confirm the predicted molecular interactions and therapeutic relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Master of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya 60131, Indonesia.
- Medical Research Center of Indonesia, Surabaya 60281, Indonesia.
- Institute for Research and Community Service, State Islamic University of Sunan Kalijaga (UIN Sunan Kalijaga), Yogyakarta 55281, Indonesia.
- Department of Pharmacy, Faculty of Medical Sciences, Albanian University, 1017 Tirana, Albania.
- Department of Cardiac Surgery, Faculty of Medicine, University Hospital Zürich, University of Zürich, Wagistrasse 12, 8952 Schlieren, Switzerland.
- Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131 Napoli, Italy.
ORCID-Profile: Fahrul Nurkolis, Antonello Santini
Förderung
- This research was funded by the Albanian University Research Fund.
- Albanian University Research Fund
Zitieren
APA
Nurkolis, F., Dama, A., Gorica, E., Santini, A., & Tjandrawinata, R. R. (2026). Phytochemical Profiling and Pharmacoinformatics Reveal Proliverenol from Phaleria macrocarpa as a Multi-Target Hepatoprotective Modulator of MAFLD. Pharmaceuticals, 19(3), 491. https://doi.org/10.3390/ph19030491
Vancouver
Nurkolis F, Dama A, Gorica E, Santini A, Tjandrawinata RR. Phytochemical Profiling and Pharmacoinformatics Reveal Proliverenol from Phaleria macrocarpa as a Multi-Target Hepatoprotective Modulator of MAFLD. Pharmaceuticals. 2026;19(3):491. doi:10.3390/ph19030491
BibTeX
@article{Nurkolis2026,
author = {Nurkolis, Fahrul and Dama, Aida and Gorica, Era and Santini, Antonello and Tjandrawinata, Raymond Rubianto},
title = {Phytochemical Profiling and Pharmacoinformatics Reveal Proliverenol from Phaleria macrocarpa as a Multi-Target Hepatoprotective Modulator of MAFLD},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {3},
pages = {491},
doi = {10.3390/ph19030491}
}
EUVIMED